ABSTRACT

Fact Sheet for Healthcare Providers: Genalyte, Inc., Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2   [open pdf - 150KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Maverick SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] Multi-Antigen Serology Panel v2. [...] This test detects human SARS-CoV-2 antibodies that are generated as part of the human adaptive immune response to the COVID-19 [coronavirus disease 2019] virus and is to be performed on only human dipotassium EDTA [ethylenediaminetetraacetic acid] venous whole blood, dipotassium EDTA plasma and serum specimens."

Publisher:
Date:
2020-10-08
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations